MEI Pharma, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
MEIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
11455 El Camino Real, Suite 250, San Diego, CA

There are no Buy or Sell transactions made by insiders since 10/7/2024

MEI Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander Schornstein 10%+ Owner $9.56M Sep 9, 2025
Anson Funds Management LP 10%+ Owner $7.65M Oct 20, 2023
Funicular Funds, LP 10%+ Owner $4.28M Oct 20, 2023
Charles V. Baltic III Director $778K Sep 29, 2023
Charles Benjamin Lee Director $640K Oct 3, 2025
Steven D. Wood Director $158K Jul 15, 2025
James P. Flynn Director $45.5K Oct 1, 2025
Frederick Driscoll Director $4.11K Jul 15, 2025
Thomas C. Reynolds Director $1.1K Jul 15, 2025
Justin J. File Secretary, Acting CEO & CFO Jul 15, 2025
Nicholas Glover Director Jul 15, 2025
Joshua Riezman Director Aug 8, 2025
Christine Anna White Director Jul 5, 2022
Cheryl Cohen Director Jul 5, 2022
Kevan Clemens Director Jul 1, 2021
Sujay Kango Director Sep 29, 2023
Richard G. Ghalie Chief Medical Officer Sep 29, 2023
Taheer Datoo Director Oct 31, 2023
Brian G. Drazba Chief Financial Officer Jul 5, 2022
David M. Urso President and CEO, Director Jun 2, 2023
Daniel P. Gold Phd Director Sep 29, 2023
Tamar Howson Director Sep 29, 2023

Recent Insider Transactions by Companies or Individuals for MEI Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.